The Discounted Cash Flow (DCF) valuation of Intellia Therapeutics Inc (NTLA) is (232.42) USD. With the latest stock price at 13.56 USD, the upside of Intellia Therapeutics Inc based on DCF is -1814.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 7.9% | 6.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (742.60) - (140.60) | (232.42) |
| Upside | -5576.4% - -1136.9% | -1814.0% |